Notably, the tumor also exhibited a double expressor lymphoma (DEL) phenotype, with Bcl-2 expression at 95% and c-Myc expression at 70%, suggesting aggressive biological behavior that may have contributed to the rapid disease progression (19). The gene discussed is BCL2; the disease is neoplasm.